Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene expression profiling in chronic inflammatory demyelinating polyneuropathy.

Susanne Renaud1, Arthur P Hays, Thomas H Brannagan

  • 1Department of Neurology and Neurosciences, Weill Medical College, Cornell University, New York, NY, USA. susanne.renaud@unibas.ch

Journal of Neuroimmunology
|January 18, 2005
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The prospects of CAR T-cell therapies in changing the therapeutic algorithm of neurologic autoimmunities.

Therapeutic advances in neurological disorders·2026
Same author

Risk of intracranial haemorrhage in patients with acute ischaemic stroke and prior antiplatelet therapy.

European stroke journal·2026
Same author

Autoimmune encephalitis, autoimmune dementias, and autoimmune psychotic disorders.

Handbook of clinical neurology·2026
Same author

Intravenous immunoglobulin use in neurology.

Handbook of clinical neurology·2026
Same author

Progress of neuroimmunotherapies: Witnessing an impressive success in the treatment of neurologic autoimmunities.

Handbook of clinical neurology·2026
Same author

Immunobiology and immunotherapies in stiff-person syndrome and glutamic acid decarboxylase antibody-spectrum disorders: Present and future therapeutic prospects.

Handbook of clinical neurology·2026

Gene expression analysis in sural nerve biopsies revealed distinct patterns for chronic inflammatory demyelinating polyneuropathy (CIDP) and vasculitic neuropathy. This study identified potential biomarkers for disease identification and pathogenesis.

Area of Science:

  • Neurology
  • Molecular Biology
  • Genomics

Background:

  • Chronic inflammatory demyelinating polyneuropathy (CIDP) and vasculitic neuropathy (VAS) are distinct nerve disorders.
  • Understanding differential gene expression in sural nerve biopsies is crucial for diagnosis and pathogenesis research.

Purpose of the Study:

  • To compare gene expression profiles in sural nerve biopsies from patients with CIDP, VAS, and normal nerve (NN) tissue.
  • To identify specific genes associated with the pathogenesis of CIDP and VAS.

Main Methods:

  • DNA microarray technology was employed to analyze gene expression.
  • Hierarchical clustering analysis was used to identify distinct gene expression patterns among the disease groups.

Main Results:

Related Experiment Videos

  • Distinct gene expression patterns were observed, differentiating CIDP, VAS, and NN.
  • Tachykinin precursor 1 (pain mediation), Stearoyl-CoA-desaturase (potential remyelination marker), and Allograft Inflammatory Factor 1 (AIF-1; immune response modulation) were identified as key genes of interest.

Conclusions:

  • Differential gene expression in sural nerve biopsies can aid in distinguishing between CIDP, VAS, and NN.
  • Identified genes may play significant roles in the pathogenesis of these neuropathies.